What were thought to be 'perimenopause symptoms' had in fact been the first signs of her cancer.

A hot flush is a phenomenon as disruptive as it is commonplace. One moment, life proceeds as usual. The next, a wave of heat rises, spreading from the chest to the face—leaving behind flushed skin and ...

Add Yahoo as a preferred source to see more of our stories on Google. Women in the UK will soon have access to a new daily pill designed to alleviate hot flushes during menopause, following its ...

Hot flushes are one of the most distressing conditions faced by women who have been treated for breast cancer, but they are not being adequately addressed by healthcare professionals and some women ...

Have you heard the (health) news? A new drug is going to be offering on the NHS, and it could provide an alternative option for women experiencing menopause symptoms – namely, hot flushes. The drug is ...

Hot flushes are one of the more bothersome symptoms of menopause. Traditionally treated with estrogens, alternative medications have been sought to avoid the risks of hormone replacement therapy. A ...

If you're in perimenopause or menopause, you likely know exactly what we mean when we talk about the agony of hot flushes (or hot flashes for our US readers). It's that sudden sensation of heat rising ...

Go to source) The new data from the OASIS-4 clinical trial. Presented by Professor Fatima Cardoso at the 15th European Breast Cancer Conference (EBCC15), the latest analysis proves that non-hormonal ...

Menopause is the stage of life where the ovaries stop releasing eggs and menstrual periods cease. Most Australian women go through menopause between 45 and 55 years of age, with the average age being ...

European regulators have backed the approval of Lynkuet (elinzanetant, Bayer AG) for treating moderate-to-severe vasomotor symptoms (VMS). The drug targets hot flushes (also known as hot flashes) ...

Hormone-replacement therapy (HRT) can effectively treat menopausal hot flushes, but is contraindicated in many women. A new study has now demonstrated that a neurokinin 3 receptor (NK3R) antagonist ...